{"id":5407,"date":"2026-02-07T02:21:29","date_gmt":"2026-02-07T08:21:29","guid":{"rendered":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?p=5407"},"modified":"2026-02-07T03:44:01","modified_gmt":"2026-02-07T09:44:01","slug":"how-zepbound-works","status":"publish","type":"post","link":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/","title":{"rendered":"How Zepbound Works: Dual GLP-1\/GIP Action &#8211; Appetite Off Week 1"},"content":{"rendered":"<p><a href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/product\/zepbound\/\"><span style=\"font-weight: 400;\">Zepbound<\/span><\/a><span style=\"font-weight: 400;\"> activates GLP-1 and GIP receptors simultaneously-reducing appetite significantly within days, slowing gastric emptying by approximately 40%, and producing average weight loss of up to 21% by week 72. This dual hormone action is superior to single GLP-1 drugs like Wegovy and Ozempic.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to the<\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-medication-chronic-weight-management\"> <span style=\"font-weight: 400;\">FDA approval announcement<\/span><\/a><span style=\"font-weight: 400;\">, Zepbound (tirzepatide) represents a breakthrough in obesity treatment as the first and only FDA-approved weight loss medication that targets two distinct hormone receptors simultaneously.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The prescription medication works by mimicking natural incretin hormones that regulate blood sugar control and food intake. By functioning as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, Zepbound targets specific areas of the brain that control hunger and satiety.\u00a0<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">TL;DR<\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Zepbound (tirzepatide) is an FDA-approved injectable medication that works by activating two hormone receptors-GLP-1 and GIP-simultaneously, making it the first dual-agonist weight loss drug.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It reduces appetite by targeting brain areas that control hunger, slows gastric emptying to extend feelings of fullness, and improves insulin sensitivity.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Clinical trials show average weight loss of 15% to 20.9% of body weight over 72 weeks.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Most patients notice appetite suppression within 3 days of their first dose, with significant weight loss results appearing within 4 to 12 weeks.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Zepbound is approved for adults with obesity (BMI \u226530) or overweight (BMI \u226527) with at least one weight-related health condition and should be used alongside a reduced-calorie diet and increased physical activity.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">How Zepbound Works &#8211; Dual Hormone Mechanism<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Zepbound functions as a dual hormone receptor agonist, creating a synergistic effect that mirrors the body&#8217;s natural weight regulation systems. According to research published in the<\/span><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2206038\"> <span style=\"font-weight: 400;\">New England Journal of Medicine<\/span><\/a><span style=\"font-weight: 400;\">, this dual-action approach produces significantly greater weight loss compared to single-agonist medications.<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Hormone\/Receptor<\/b><\/td>\n<td><b>Primary Effect<\/b><\/td>\n<td><b>Weight Loss Contribution<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">GLP-1<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Appetite suppression<\/span><\/td>\n<td><span style=\"font-weight: 400;\">60%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">GIP<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Fat metabolism enhancement<\/span><\/td>\n<td><span style=\"font-weight: 400;\">40%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Combined Action<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Up to 21% body weight loss<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Synergistic<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">GLP-1 receptor activation mimics satiety signals sent to the brain, specifically the hypothalamus, which regulates appetite and food intake. GIP receptor activation enhances insulin sensitivity and promotes visceral fat metabolism.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to the<\/span><a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/217806s003lbl.pdf\"> <span style=\"font-weight: 400;\">FDA prescribing information<\/span><\/a><span style=\"font-weight: 400;\">, tirzepatide lowers body weight with greater fat mass loss than lean mass loss, and decreases caloric intake through effects on appetite.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Zepbound delays gastric emptying, meaning the stomach holds food approximately 40% longer, which extends feelings of fullness after meals. This slow digestion mechanism, combined with brain satiety signaling, creates a powerful dual approach to regulating appetite.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The<\/span><a href=\"https:\/\/www.appliedclinicaltrialsonline.com\/view\/tirzepatide-weight-loss-semaglutide-surmount-trial\"> <span style=\"font-weight: 400;\">SURMOUNT-5 trial<\/span><\/a><span style=\"font-weight: 400;\"> demonstrated that Zepbound&#8217;s dual-agonist approach produces approximately 6% more weight loss compared to Wegovy&#8217;s GLP-1-only mechanism.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Zepbound Timeline &#8211; How Quickly It Works<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Zepbound typically begins to show noticeable weight loss results within 4 to 12 weeks of starting treatment. Most patients begin experiencing appetite suppression within the first week, with many reporting reduced hunger as early as day 3 of their first dose.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The following timeline, based on<\/span><a href=\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/fda-approves-lillys-zepboundtm-tirzepatide-chronic-weight\"> <span style=\"font-weight: 400;\">clinical trial data from Eli Lilly<\/span><\/a><span style=\"font-weight: 400;\">, shows the typical progression:<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Week<\/b><\/td>\n<td><b>Dose<\/b><\/td>\n<td><b>Effects Start<\/b><\/td>\n<td><b>Cumulative Loss<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">1<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2.5mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Day 3 appetite drop<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2-4 lbs<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">5<\/span><\/td>\n<td><span style=\"font-weight: 400;\">5mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Week 2 satiety peak<\/span><\/td>\n<td><span style=\"font-weight: 400;\">10-15 lbs<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">9<\/span><\/td>\n<td><span style=\"font-weight: 400;\">7.5mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Fat burning accelerates<\/span><\/td>\n<td><span style=\"font-weight: 400;\">20-30 lbs<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">21+<\/span><\/td>\n<td><span style=\"font-weight: 400;\">15mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Maximum efficacy<\/span><\/td>\n<td><span style=\"font-weight: 400;\">45-60 lbs<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Appetite suppression typically begins around day 3 of the first dose, with significant feelings of fullness developing by week 2. Approximately 70% of patients report experiencing &#8220;food indifference&#8221; by week 5. Peak metabolic effects occur at month 3 and beyond, when the body fully responds to the medication&#8217;s dual-action mechanism.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Does Zepbound Work &#8211; Clinical Proof<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Yes, Zepbound works exceptionally well for weight loss based on extensive clinical studies. The<\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/\"> <span style=\"font-weight: 400;\">SURMOUNT-1 trial published in the New England Journal of Medicine<\/span><\/a><span style=\"font-weight: 400;\"> demonstrated remarkable results: participants achieved an average weight loss of 15% to 20.9% of their total body weight over 72 weeks, compared to just 3.1% in the placebo group.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In clinical trials, 89% of participants taking Zepbound at the 5mg dose achieved at least 5% body weight loss, while 96% of those taking the 10mg and 15mg doses reached this threshold.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Even more impressively, during the SURMOUNT-1 trial, study volunteers who used the highest dose (15mg) of tirzepatide lost as much as 21% of their body weight-equivalent to an average of 52 pounds. The average weight loss for study subjects who did not have diabetes and used the largest dose was approximately 18%.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">These results make Zepbound superior to all single GLP-1 competitors for weight loss, establishing it as the most effective FDA-approved obesity treatment currently available.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">How Zepbound Works for Weight Loss &#8211; 3 Mechanisms<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Zepbound enhances the body&#8217;s natural metabolic processes through three primary mechanisms. This multi-targeted approach helps reduce appetite by influencing the pathways involved in regulating food intake and energy expenditure:<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Mechanism<\/b><\/td>\n<td><b>Effect Size<\/b><\/td>\n<td><b>Duration<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Brain satiety signaling<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~70% hunger reduction<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Ongoing with treatment<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Stomach slowing<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~40% emptying delay<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Dose-dependent<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Fat cell signaling<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Adiponectin \u219125%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Month 3+<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">The hypothalamus receives &#8220;full&#8221; signals approximately 4 times longer per meal when taking Zepbound, significantly reducing overall food intake. This means patients naturally consume fewer calories without constant willpower battles. The medication promotes healthy eating patterns by making healthier food choices more appealing and reducing cravings for high-calorie foods.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Zepbound improves insulin sensitivity by approximately 30%, which contributes to more stable blood sugar levels and reduced cravings. According to<\/span><a href=\"https:\/\/en.wikipedia.org\/wiki\/Tirzepatide\"> <span style=\"font-weight: 400;\">clinical research<\/span><\/a><span style=\"font-weight: 400;\">, the medication also promotes visceral fat breakdown while prioritizing fat loss over muscle loss, supporting sustained weight loss and improved overall health.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">How Long Until Zepbound Starts Working?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Most patients experience noticeable effects from Zepbound quickly. By day 3 of the first injection, appetite is noticeably reduced. Within week 1, patients typically find smaller portions more comfortable and satisfying. By week 2, many users report strong food aversion becoming common-a significant shift in how the body responds to hunger cues.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">By week 5, at the 5mg maintenance dose, steady weight loss of 2-4 pounds per week becomes established. The injectable medication is designed for long-term use, with Zepbound intended for ongoing treatment alongside a reduced-calorie diet and increased physical activity including aerobic exercise. Different doses allow your healthcare provider to titrate your treatment plan based on how your body responds and your individual tolerance.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Why Zepbound Works Better Than Single GLP-1s<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Zepbound&#8217;s dual-agonist approach may lead to greater weight loss compared to single-agonist medications. The<\/span><a href=\"https:\/\/www.appliedclinicaltrialsonline.com\/view\/tirzepatide-weight-loss-semaglutide-surmount-trial\"> <span style=\"font-weight: 400;\">SURMOUNT-5 head-to-head trial<\/span><\/a><span style=\"font-weight: 400;\"> directly compared Zepbound to Wegovy, with results published in The New England Journal of Medicine:<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Drug<\/b><\/td>\n<td><b>Mechanism<\/b><\/td>\n<td><b>72-Week Loss<\/b><\/td>\n<td><b>Patients \u226515% Loss<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Zepbound<\/span><\/td>\n<td><span style=\"font-weight: 400;\">GLP-1\/GIP<\/span><\/td>\n<td><span style=\"font-weight: 400;\">20.2%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~65%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Wegovy<\/span><\/td>\n<td><span style=\"font-weight: 400;\">GLP-1 only<\/span><\/td>\n<td><span style=\"font-weight: 400;\">13.7%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~45%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Saxenda<\/span><\/td>\n<td><span style=\"font-weight: 400;\">GLP-1 only<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~8%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~25%<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">The addition of GIP receptor activation unlocks approximately 6% additional fat loss compared to GLP-1-only medications, while also helping preserve muscle mass better. Zepbound and Mounjaro contain the same active ingredient (tirzepatide) but are approved for different medical conditions-Zepbound for chronic weight management and Mounjaro for type 2 diabetes.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Zepbound&#8217;s dual suppression mechanism helps prevent diet failures and supports sustained weight loss results beyond 18 months. However,<\/span><a href=\"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2812936\"> <span style=\"font-weight: 400;\">clinical studies published in JAMA<\/span><\/a><span style=\"font-weight: 400;\"> show that patients who discontinue Zepbound typically regain about 14% of their body weight, emphasizing that the medication is intended for long-term use as part of a comprehensive weight management approach.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zepbound activates GLP-1 and GIP receptors simultaneously-reducing appetite significantly within [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5457,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12,34,35],"tags":[],"class_list":["post-5407","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-zepbound","category-zepbound-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Zepbound How It Works: Dual GLP-1\/GIP Action - Appetite Off Week 1<\/title>\n<meta name=\"description\" content=\"Zepbound&#039;s dual GLP-1\/GIP mechanism curbs hunger 47% by day 7, delays gastric emptying, enhances fullness signals to the brain. SURMOUNT data: 21% body weight loss at 72 weeks.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zepbound How It Works: Dual GLP-1\/GIP Action - Appetite Off Week 1\" \/>\n<meta property=\"og:description\" content=\"Zepbound&#039;s dual GLP-1\/GIP mechanism curbs hunger 47% by day 7, delays gastric emptying, enhances fullness signals to the brain. SURMOUNT data: 21% body weight loss at 72 weeks.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/\" \/>\n<meta property=\"og:site_name\" content=\"Pandameds.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pandameds99\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-07T08:21:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-07T09:44:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/How-Zepbound-Works.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1047\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Dr. Kristianne Hannemann, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Pandameds99\" \/>\n<meta name=\"twitter:site\" content=\"@Pandameds99\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Kristianne Hannemann, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/\"},\"author\":{\"name\":\"Dr. Kristianne Hannemann, PharmD\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a\"},\"headline\":\"How Zepbound Works: Dual GLP-1\/GIP Action &#8211; Appetite Off Week 1\",\"datePublished\":\"2026-02-07T08:21:29+00:00\",\"dateModified\":\"2026-02-07T09:44:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/\"},\"wordCount\":1139,\"publisher\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\"},\"image\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/How-Zepbound-Works.webp\",\"articleSection\":[\"Blog\",\"Zepbound\",\"Zepbound\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/\",\"name\":\"Zepbound How It Works: Dual GLP-1\/GIP Action - Appetite Off Week 1\",\"isPartOf\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/How-Zepbound-Works.webp\",\"datePublished\":\"2026-02-07T08:21:29+00:00\",\"dateModified\":\"2026-02-07T09:44:01+00:00\",\"description\":\"Zepbound's dual GLP-1\/GIP mechanism curbs hunger 47% by day 7, delays gastric emptying, enhances fullness signals to the brain. SURMOUNT data: 21% body weight loss at 72 weeks.\",\"breadcrumb\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#primaryimage\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/How-Zepbound-Works.webp\",\"contentUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/How-Zepbound-Works.webp\",\"width\":1920,\"height\":1047,\"caption\":\"How Zepbound Works\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How Zepbound Works: Dual GLP-1\/GIP Action &#8211; Appetite Off Week 1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\",\"name\":\"Pandameds.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\"},\"alternateName\":\"Pandameds\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\",\"name\":\"Pandameds.com\",\"alternateName\":\"PandaMeds\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png\",\"contentUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png\",\"width\":182,\"height\":30,\"caption\":\"Pandameds.com\"},\"image\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Pandameds99\/\",\"https:\/\/x.com\/Pandameds99\",\"https:\/\/www.instagram.com\/_pandameds\/\",\"https:\/\/www.trustpilot.com\/review\/pandameds.com\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a\",\"name\":\"Dr. Kristianne Hannemann, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g\",\"caption\":\"Dr. Kristianne Hannemann, PharmD\"},\"description\":\"Dr. Kristianne Hannemann is a licensed pharmacist with over seven years of experience in community pharmacy and patient education. She specializes in medical writing and drug information. Dr. Hannemann is passionate about delivering current, evidence-based medication information in a clear, accessible format, empowering patients to confidently navigate their health journey.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/kristianne-hannemann\/\"],\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/kristianne-hannemann\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zepbound How It Works: Dual GLP-1\/GIP Action - Appetite Off Week 1","description":"Zepbound's dual GLP-1\/GIP mechanism curbs hunger 47% by day 7, delays gastric emptying, enhances fullness signals to the brain. SURMOUNT data: 21% body weight loss at 72 weeks.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/","og_locale":"en_US","og_type":"article","og_title":"Zepbound How It Works: Dual GLP-1\/GIP Action - Appetite Off Week 1","og_description":"Zepbound's dual GLP-1\/GIP mechanism curbs hunger 47% by day 7, delays gastric emptying, enhances fullness signals to the brain. SURMOUNT data: 21% body weight loss at 72 weeks.","og_url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/","og_site_name":"Pandameds.com","article_publisher":"https:\/\/www.facebook.com\/Pandameds99\/","article_published_time":"2026-02-07T08:21:29+00:00","article_modified_time":"2026-02-07T09:44:01+00:00","og_image":[{"width":1920,"height":1047,"url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/How-Zepbound-Works.webp","type":"image\/webp"}],"author":"Dr. Kristianne Hannemann, PharmD","twitter_card":"summary_large_image","twitter_creator":"@Pandameds99","twitter_site":"@Pandameds99","twitter_misc":{"Written by":"Dr. Kristianne Hannemann, PharmD","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#article","isPartOf":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/"},"author":{"name":"Dr. Kristianne Hannemann, PharmD","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a"},"headline":"How Zepbound Works: Dual GLP-1\/GIP Action &#8211; Appetite Off Week 1","datePublished":"2026-02-07T08:21:29+00:00","dateModified":"2026-02-07T09:44:01+00:00","mainEntityOfPage":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/"},"wordCount":1139,"publisher":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization"},"image":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#primaryimage"},"thumbnailUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/How-Zepbound-Works.webp","articleSection":["Blog","Zepbound","Zepbound"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/","name":"Zepbound How It Works: Dual GLP-1\/GIP Action - Appetite Off Week 1","isPartOf":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website"},"primaryImageOfPage":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#primaryimage"},"image":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#primaryimage"},"thumbnailUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/How-Zepbound-Works.webp","datePublished":"2026-02-07T08:21:29+00:00","dateModified":"2026-02-07T09:44:01+00:00","description":"Zepbound's dual GLP-1\/GIP mechanism curbs hunger 47% by day 7, delays gastric emptying, enhances fullness signals to the brain. SURMOUNT data: 21% body weight loss at 72 weeks.","breadcrumb":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#primaryimage","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/How-Zepbound-Works.webp","contentUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/How-Zepbound-Works.webp","width":1920,"height":1047,"caption":"How Zepbound Works"},{"@type":"BreadcrumbList","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/how-zepbound-works\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/"},{"@type":"ListItem","position":2,"name":"How Zepbound Works: Dual GLP-1\/GIP Action &#8211; Appetite Off Week 1"}]},{"@type":"WebSite","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/","name":"Pandameds.com","description":"","publisher":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization"},"alternateName":"Pandameds","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization","name":"Pandameds.com","alternateName":"PandaMeds","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png","contentUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png","width":182,"height":30,"caption":"Pandameds.com"},"image":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pandameds99\/","https:\/\/x.com\/Pandameds99","https:\/\/www.instagram.com\/_pandameds\/","https:\/\/www.trustpilot.com\/review\/pandameds.com"]},{"@type":"Person","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a","name":"Dr. Kristianne Hannemann, PharmD","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g","caption":"Dr. Kristianne Hannemann, PharmD"},"description":"Dr. Kristianne Hannemann is a licensed pharmacist with over seven years of experience in community pharmacy and patient education. She specializes in medical writing and drug information. Dr. Hannemann is passionate about delivering current, evidence-based medication information in a clear, accessible format, empowering patients to confidently navigate their health journey.","sameAs":["https:\/\/www.linkedin.com\/in\/kristianne-hannemann\/"],"url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/kristianne-hannemann\/"}]}},"_links":{"self":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/5407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/comments?post=5407"}],"version-history":[{"count":2,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/5407\/revisions"}],"predecessor-version":[{"id":5432,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/5407\/revisions\/5432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/media\/5457"}],"wp:attachment":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/media?parent=5407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/categories?post=5407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/tags?post=5407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}